Covid Booster Price Increases Being Considered Due To A Drop In Demand
In recent months, a large proportion of Americans are delaying or skipping new COVID-19 booster shots, and analysts and investors predict far fewer will be administered each year, bringing the total number of shots well below annual flu vaccinations. With fewer shots required, vaccine makers such as Pfizer Inc, partner BioNTech SE, rival Moderna Inc,…









